NR3C2 and arteriosclerosis: Secondly, data regarding the use of mineralocorticoid receptor antagonist medications were not available, which may be related to the prognosis of kidney function and we did not record the events of myocardial infarction and stroke, or other cardiovascular diseases that are associated with arteriosclerosis.